Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections.

MLA

Garcia, Mario D., et al. “Commercial AHAS-Inhibiting Herbicides Are Promising Drug Leads for the Treatment of Human Fungal Pathogenic Infections.” Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 41, Oct. 2018, pp. E9649–58. EBSCOhost, https://doi.org/10.1073/pnas.1809422115.

APA

Garcia, M. D., Chua, S. M. H., Yu-Shang Low, Yu-Ting Lee, Agnew-Francis, K., Jian-Guo Wang, Nouwens, A., Lonhienne, T., Williams, C. M., Fraser, J. A., & Guddat, L. W. (2018). Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections. Proceedings of the National Academy of Sciences of the United States of America, 115(41), E9649–E9658. https://doi.org/10.1073/pnas.1809422115

Chicago

Garcia, Mario D., Sheena M. H. Chua, Yu-Shang Low, Yu-Ting Lee, Kylie Agnew-Francis, Jian-Guo Wang, Amanda Nouwens, et al. 2018. “Commercial AHAS-Inhibiting Herbicides Are Promising Drug Leads for the Treatment of Human Fungal Pathogenic Infections.” Proceedings of the National Academy of Sciences of the United States of America 115 (41): E9649–58. doi:10.1073/pnas.1809422115.